Cite
HARVARD Citation
Perumal, R. et al. (2020). A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial. Clinical infectious diseases. pp. 90-98. [Online].